Literature DB >> 16629849

Measurement and meaning of apolipoprotein AI and apolipoprotein B plasma levels.

S Marcovina1, C J Packard.   

Abstract

Apolipoproteins AI and B are structural components of lipoprotein particles, and also determinants of the metabolic fate of the encapsulated lipid, cholesterol and triglyceride. Development of accurate assays for these apolipoproteins has opened the way for their use as predictors of coronary heart disease risk. Interpretation of AI and apo B levels is best undertaken with background knowledge of the metabolic status of an individual, especially the lipolytic capacity as reflected in the triglyceride concentration. Those with raised triglyceride, in general, not only have an elevated apo B/apo AI ratio, but also apo B-containing lipoproteins with a prolonged residence time and hence ample opportunity for modification and damage. Assessment of apolipoprotein levels is an aid to risk prediction and can be useful in tailoring treatment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16629849     DOI: 10.1111/j.1365-2796.2006.01648.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  50 in total

1.  Reduced cardiovascular risk after bariatric surgery is linked to plasma ceramides, apolipoprotein-B100, and ApoB100/A1 ratio.

Authors:  Helen M Heneghan; Hazel Huang; Sangeeta R Kashyap; Heather L Gornik; Arthur J McCullough; Philip R Schauer; Stacy A Brethauer; John P Kirwan; Takhar Kasumov
Journal:  Surg Obes Relat Dis       Date:  2011-12-20       Impact factor: 4.734

2.  A high-throughput mass spectrometry-based assay for large-scale profiling of circulating human apolipoproteins.

Authors:  Valentin Blanchard; Damien Garçon; Catherine Jaunet; Kevin Chemello; Stéphanie Billon-Crossouard; Audrey Aguesse; Aya Garfa; Gilles Famchon; Amada Torres; Cédric Le May; Matthieu Pichelin; Edith Bigot-Corbel; Gilles Lambert; Bertrand Cariou; Samy Hadjadj; Michel Krempf; Kalyane Bach-Ngohou; Mikaël Croyal
Journal:  J Lipid Res       Date:  2020-05-13       Impact factor: 5.922

Review 3.  The relationship between high density lipoprotein subclass profile and apolipoprotein concentrations.

Authors:  L Tian; M Fu
Journal:  J Endocrinol Invest       Date:  2011-06       Impact factor: 4.256

4.  Lipoprotein Biomarkers and Risk of Cardiovascular Disease: A Laboratory Medicine Best Practices (LMBP) Systematic Review.

Authors:  Paramjit K Sandhu; Salma M A Musaad; Alan T Remaley; Stephanie S Buehler; Sonya Strider; James H Derzon; Hubert W Vesper; Anne Ranne; Colleen S Shaw; Robert H Christenson
Journal:  J Appl Lab Med       Date:  2016-08-01

5.  The effect of an energy restricted low glycemic index diet on blood lipids, apolipoproteins and lipoprotein (a) among adolescent girls with excess weight: a randomized clinical trial.

Authors:  Mohammad Hossein Rouhani; Roya Kelishadi; Mahin Hashemipour; Ahmad Esmaillzadeh; Leila Azadbakht
Journal:  Lipids       Date:  2013-09-03       Impact factor: 1.880

Review 6.  Dyslipidemia and diabetic retinopathy.

Authors:  Yo-Chen Chang; Wen-Chuan Wu
Journal:  Rev Diabet Stud       Date:  2013-08-10

Review 7.  Whole exome sequencing identification of novel candidate genes in patients with proliferative diabetic retinopathy.

Authors:  Cindy Ung; Angie V Sanchez; Lishuang Shen; Samaneh Davoudi; Tina Ahmadi; Daniel Navarro-Gomez; Ching J Chen; Heather Hancock; Alan Penman; Suzanne Hoadley; Mark Consugar; Carlos Restrepo; Vinay A Shah; Joseph F Arboleda-Velasquez; Lucia Sobrin; Xiaowu Gai; Leo A Kim
Journal:  Vision Res       Date:  2017-05-09       Impact factor: 1.886

8.  Consumption of fructose-sweetened beverages for 10 weeks increases postprandial triacylglycerol and apolipoprotein-B concentrations in overweight and obese women.

Authors:  Michael M Swarbrick; Kimber L Stanhope; Sharon S Elliott; James L Graham; Ronald M Krauss; Mark P Christiansen; Steven C Griffen; Nancy L Keim; Peter J Havel
Journal:  Br J Nutr       Date:  2008-11       Impact factor: 3.718

9.  Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans.

Authors:  Kimber L Stanhope; Jean Marc Schwarz; Nancy L Keim; Steven C Griffen; Andrew A Bremer; James L Graham; Bonnie Hatcher; Chad L Cox; Artem Dyachenko; Wei Zhang; John P McGahan; Anthony Seibert; Ronald M Krauss; Sally Chiu; Ernst J Schaefer; Masumi Ai; Seiko Otokozawa; Katsuyuki Nakajima; Takamitsu Nakano; Carine Beysen; Marc K Hellerstein; Lars Berglund; Peter J Havel
Journal:  J Clin Invest       Date:  2009-04-20       Impact factor: 14.808

10.  Fructose consumption: considerations for future research on its effects on adipose distribution, lipid metabolism, and insulin sensitivity in humans.

Authors:  Kimber L Stanhope; Peter J Havel
Journal:  J Nutr       Date:  2009-04-29       Impact factor: 4.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.